<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-----------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Rigel Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 94-3248524
- ------------------------------------------- -----------------------------------
(State of Incorporation or Organization) (I.R.S. Employer Identification No.)
240 East Grand Avenue, S. San Francisco, CA 94080
- ------------------------------------------- -----------------------------------
(Address of principal executive offices) (Zip code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. / /
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following. /x/
Securities Act registration statement number to which this form relates:
333-96127
1.
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Common Stock to be registered hereunder is contained
in the section entitled "Description of securities," commencing at page 64 of
the Prospectus included in the Registrant's Form S-1 Registration Statement, as
amended (No 333-96127), initially filed with the Securities and Exchange
Commission (the "Commission") on February 4, 2000 (the "Registration Statement")
and incorporated herein by reference.
ITEM 2. EXHIBITS.
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
<S> <C>
3.1 Amended and Restated Certificate of Incorporation of Registrant (1)
3.2 Amended and Restated Bylaws of Registrant (1)
4.1 Specimen Stock Certificate (2)
</TABLE>
- -----
(1) Filed as an exhibit to the Registration Statement and incorporated herein
by reference.
(2) To be filed be amendment.
2.
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized.
Rigel Pharmaceuticals, Inc.
---------------------------
(Registrant)
Date: March 8, 2000 By: /s/ Brian C. Cunningham
-------------------------
Brian C. Cunningham
3.